A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tranylcypromine
Dabrafenib
The serum concentration of Sertraline can be decreased when it is combined with Dabrafenib.
Tranylcypromine
Thalidomide
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Tranylcypromine
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Sertraline.
Tranylcypromine
Suvorexant
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tranylcypromine
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Sertraline.
Tranylcypromine
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Sertraline.
Tranylcypromine
Rotigotine
Sertraline may increase the sedative activities of Rotigotine.
Tranylcypromine
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Sertraline.
Tranylcypromine
Paraldehyde
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Tranylcypromine
Orphenadrine
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Tranylcypromine
Methotrimeprazine
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Tranylcypromine
Hydrocodone
Sertraline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Tranylcypromine
Metyrosine
The risk or severity of extrapyramidal symptoms can be increased when Metyrosine is combined with Sertraline.
Tranylcypromine
Ioflupane I-123
Sertraline may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
Tranylcypromine
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Sertraline.
Prilocaine
Satralizumab
The serum concentration of Quinacrine can be decreased when it is combined with Satralizumab.
Prilocaine
Abametapir
The serum concentration of Quinacrine can be increased when it is combined with Abametapir.
Prilocaine
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Quinacrine.
Prilocaine
Cenobamate
The serum concentration of Quinacrine can be decreased when it is combined with Cenobamate.
Prilocaine
Dalfampridine
The serum concentration of Dalfampridine can be increased when it is combined with Quinacrine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3